26
DVT & PE DVT & PE By By Dr. Khattab KAEO Dr. Khattab KAEO Prof. of Obstetrics and Prof. of Obstetrics and Gynaecology Gynaecology Faculty of Medicine, Al-Azhar Faculty of Medicine, Al-Azhar University, Damietta University, Damietta

DVT & PE

  • Upload
    eara

  • View
    57

  • Download
    0

Embed Size (px)

DESCRIPTION

DVT & PE. By Dr. Khattab KAEO Prof. of Obstetrics and Gynaecology Faculty of Medicine, Al-Azhar University, Damietta. Incidence = 0.6 in 1000 pregnancy. Pregnan increases the risk by 6- 10-x The risk is 3.5-x greater after delivery than during pregnancy. - PowerPoint PPT Presentation

Citation preview

Page 1: DVT & PE

DVT & PEDVT & PEBy By

Dr. Khattab KAEODr. Khattab KAEO

Prof. of Obstetrics and Gynaecology Prof. of Obstetrics and Gynaecology Faculty of Medicine, Al-Azhar Faculty of Medicine, Al-Azhar

University, DamiettaUniversity, Damietta

Page 2: DVT & PE

IncidenceIncidence = 0.6 in 1000 pregnancy. = 0.6 in 1000 pregnancy.

Pregnan increases the risk by 6-Pregnan increases the risk by 6-10-x 10-x

The risk is 3.5-x greater after delivery The risk is 3.5-x greater after delivery than during pregnancy. than during pregnancy.

The risk is 2-4-x the risk with COC pills; & The risk is 2-4-x the risk with COC pills; &

= 6-x the risk in general popul. females= 6-x the risk in general popul. females

Page 3: DVT & PE

Risk factors in pregnancy:Risk factors in pregnancy: -Alteration in thromb & clot lysis systems. -Alteration in thromb & clot lysis systems.

This plays a minor role in VTE in pregn. This plays a minor role in VTE in pregn. except in cases of dehydration as in except in cases of dehydration as in hyperemesis gravidarum, and if the hyperemesis gravidarum, and if the intravascular fluid vol. is reduced as in intravascular fluid vol. is reduced as in preeclampsia. Thrombophilias play an preeclampsia. Thrombophilias play an increasing role. increasing role.

- Venous stasis caused by the uterus, - Venous stasis caused by the uterus, decreased venous tone and decreased decreased venous tone and decreased circulation time circulation time (partly due to reduced activity)(partly due to reduced activity) Other factors not specific to pregnancy Other factors not specific to pregnancy that cause venous stasis include plane that cause venous stasis include plane journey of >3 h and bed rest. journey of >3 h and bed rest.

--Vascular damage canbe caused by hypert Vascular damage canbe caused by hypert surgery & infection. The risk after CS is surgery & infection. The risk after CS is 5-x > after vaginal delivery. 5-x > after vaginal delivery.

Page 4: DVT & PE

- Other factors include:*- Other factors include:*AgeAge, ≥3 parity, use of , ≥3 parity, use of estrogen to suppress lactation, sickle cell estrogen to suppress lactation, sickle cell anemia, smoking & paraplegia. Anemia, anemia, smoking & paraplegia. Anemia, dehydration, congestive cardiac failure, dehydration, congestive cardiac failure, thrombophilias and cancer. thrombophilias and cancer.

*Recurrence rate of thromboembolism is 11%.*Recurrence rate of thromboembolism is 11%.

The previous VTE could be:The previous VTE could be:

● ● Unprovoked VTE: This is associated with Unprovoked VTE: This is associated with increased risk of recurrence compared with increased risk of recurrence compared with those provoked by a temporary risk factor. those provoked by a temporary risk factor.

● ● estrogen-provoked (estrogen-containing contra estrogen-provoked (estrogen-containing contra cep. or preg) VTE: Risk of recurrence = 10%.cep. or preg) VTE: Risk of recurrence = 10%.

●●Thrombophilia or family history-associated VTE: Thrombophilia or family history-associated VTE: Heritable thrombophilia is a weak risk factor.Heritable thrombophilia is a weak risk factor.

●●Temporary risk factor (eg major trauma or surgery):Temporary risk factor (eg major trauma or surgery): The risk of antenatal recurrence is very low.The risk of antenatal recurrence is very low.

Page 5: DVT & PE

Stratify women with previous VTE into:Stratify women with previous VTE into:1-Very high risk: Women with recurrent TE associated with 1-Very high risk: Women with recurrent TE associated with

either antithrombin deficiency or the PAPS. These women either antithrombin deficiency or the PAPS. These women require LMWH either high prophylactic (/12h) or weight-require LMWH either high prophylactic (/12h) or weight-adjusted (75% of treatment dose) antenatally & for 6 w adjusted (75% of treatment dose) antenatally & for 6 w postpartum or until converted back to warfarin.postpartum or until converted back to warfarin.

2- High risk: Women in whom VTE was unprovoked or related 2- High risk: Women in whom VTE was unprovoked or related to estrogen or who have other risk factors, a family history to estrogen or who have other risk factors, a family history of VTE in a 1of VTE in a 1stst-degree relative (sugges of thrombophilia) or -degree relative (sugges of thrombophilia) or a documented thrombophilia. These women require a documented thrombophilia. These women require thromboprophylaxis with LMWH antenatally & for 6 w thromboprophylaxis with LMWH antenatally & for 6 w postpartum. postpartum.

3- Intermediate risk: Women in whom VTE was pro-voked by 3- Intermediate risk: Women in whom VTE was pro-voked by a transient major risk factor and who have no other risk a transient major risk factor and who have no other risk factors. In these women, prophylaxis with LMWH can be factors. In these women, prophylaxis with LMWH can be withheld antenatally, provided that no additional risk withheld antenatally, provided that no additional risk factors are present (in which case they should be offered factors are present (in which case they should be offered LMWH). They require close surveillance for the LMWH). They require close surveillance for the development of other risk factors. They should be offered development of other risk factors. They should be offered thromboprophylaxis with LMWH for 6 w postpartum. thromboprophylaxis with LMWH for 6 w postpartum.

Page 6: DVT & PE

*Gross varicose veins: symptomatic, *Gross varicose veins: symptomatic, above knee or with associated above knee or with associated phlebitis/ edema/skin changes. phlebitis/ edema/skin changes.

*Obesity: >80 kg or BMI >30 kg/m*Obesity: >80 kg or BMI >30 kg/m22 pre-pregnancy or in early pregnan. pre-pregnancy or in early pregnan. Obesity is a moderate risk factor Obesity is a moderate risk factor for TE. Over-Wt (BMI 25–30) is a for TE. Over-Wt (BMI 25–30) is a weak risk factor.weak risk factor.

Page 7: DVT & PE

ScreeningScreening is indicated only in recurrent cases particularly is indicated only in recurrent cases particularly if thrombosis is arterial, in atypical sites or associated if thrombosis is arterial, in atypical sites or associated with bad obstetric history. Screen for LA and aCL with bad obstetric history. Screen for LA and aCL antibodies. If there is a family history, screen for antibodies. If there is a family history, screen for inherited thrombophilias, homocystinuria & abnormal inherited thrombophilias, homocystinuria & abnormal forms of fibrinogen. forms of fibrinogen.

Risks:Risks: TE is now the leading cause of maternal mortality TE is now the leading cause of maternal mortality (11%(11%in the UK). Deaths are evenly distributed between in the UK). Deaths are evenly distributed between the antepartum & post-partum periods. The antepartum the antepartum & post-partum periods. The antepartum cases are evenly distributed between the 3 trimesters. cases are evenly distributed between the 3 trimesters. The 1The 1stst w after delivery is the most w after delivery is the most dangerousdangerous period with period with the 1the 1stst 24h constitutes a partic. critical period. 24h constitutes a partic. critical period.

Page 8: DVT & PE

Treatment:Treatment: First ensure objective diagnosis because of the problems of First ensure objective diagnosis because of the problems of treatment in the index pregn. & prophylaxis in the future pregnancies. treatment in the index pregn. & prophylaxis in the future pregnancies.

Recognize predisposing factors & use prophylaxis in high-risk peopleRecognize predisposing factors & use prophylaxis in high-risk people

Prophylaxis:Prophylaxis: All women should undergo a documented assessment of risk All women should undergo a documented assessment of risk factors for VTE. It should constitute a principal part of routine history factors for VTE. It should constitute a principal part of routine history taking. 70% of fatal & non-fatal antenatal PE have identif. risk factors. taking. 70% of fatal & non-fatal antenatal PE have identif. risk factors. LMWH reduces VTE risk in medical and surgical patients by 60% and 70%, LMWH reduces VTE risk in medical and surgical patients by 60% and 70%, respectively. respectively.

Women with asymptomatic inherited or acqu. thromboph may be Women with asymptomatic inherited or acqu. thromboph may be managed with close surveillance. However, in women with antithrombin managed with close surveillance. However, in women with antithrombin deficiency, those with >1 thrombophilic defect or those with additional deficiency, those with >1 thrombophilic defect or those with additional risk factors prophylaxis with LMWH is consid. Women with antithrombin risk factors prophylaxis with LMWH is consid. Women with antithrombin deficiency (particularly type-1) have a very high risk of recurrence and deficiency (particularly type-1) have a very high risk of recurrence and may require intermediate or ttt doses of LMWH in pregnancy. may require intermediate or ttt doses of LMWH in pregnancy.

Women with previous TE. The risk of recurrence appears to be Women with previous TE. The risk of recurrence appears to be constant over the whole period of pregnancy. All women with prior VTE constant over the whole period of pregnancy. All women with prior VTE should receive postpartum prophylaxis. For the purposes of antenatal risk should receive postpartum prophylaxis. For the purposes of antenatal risk assessment, women with previous VTE can be stratified into those with assessment, women with previous VTE can be stratified into those with recurrent or single previous VTE.recurrent or single previous VTE.

Page 9: DVT & PE

SSingle previous VTE patients may be ingle previous VTE patients may be divided into those with divided into those with

● ● unprovoked VTE.unprovoked VTE.

● ● estrogen-provoked (E-containing estrogen-provoked (E-containing contraception or pregnancy) VTEcontraception or pregnancy) VTE

● ● thrombophilia or family history-thrombophilia or family history-associated VTE.associated VTE.

● ● temporary risk factor (e.g. major temporary risk factor (e.g. major trauma or surgery) associated VTE.trauma or surgery) associated VTE.

Page 10: DVT & PE

Many individuals with recurrent VTE will be on warfarinMany individuals with recurrent VTE will be on warfarinWomen should be counselled about the risks of Women should be counselled about the risks of

warfarin to the fetus and advised to change warfarin to the fetus and advised to change to LMWH as soon as pregnancy is confirmed, to LMWH as soon as pregnancy is confirmed, ideally within 2 w of the missed period and ideally within 2 w of the missed period and before the 6before the 6thth w w

Women not on warfarin should be advised to Women not on warfarin should be advised to start LMWH as soon as they have a +ve start LMWH as soon as they have a +ve pregnancy test.pregnancy test.

Unprovoked VTE is associated with an Unprovoked VTE is associated with an increased risk of recurrence (6%) compared increased risk of recurrence (6%) compared with those provoked by a temporary risk with those provoked by a temporary risk factor that is no longer present.factor that is no longer present.

When the previous VTE was associated with E-When the previous VTE was associated with E-contain. contraception or during previous contain. contraception or during previous pregnancy, the recurrence rate is pregnancy, the recurrence rate is approximately 10%. Most of the recurrences approximately 10%. Most of the recurrences (71%) are antenatal compared with 54% in (71%) are antenatal compared with 54% in the unprovoked group.the unprovoked group.

Page 11: DVT & PE

Heritable thrombophilia is at most a weak Heritable thrombophilia is at most a weak risk factor for recurrent VTE during risk factor for recurrent VTE during pregnancy (RR 1.9). Testing for pregnancy (RR 1.9). Testing for thrombophilia will therefore not usually thrombophilia will therefore not usually influence thromboprophylaxis in the influence thromboprophylaxis in the current pregnancy unless detected in a current pregnancy unless detected in a woman with a prior VTE related to a woman with a prior VTE related to a temporary risk factor. Investigate for temporary risk factor. Investigate for thrombophilia in the latter group when thrombophilia in the latter group when the provoking stimulus was minor (such the provoking stimulus was minor (such as long-distance travel) but not where it as long-distance travel) but not where it was major (such as surgery or major was major (such as surgery or major trauma with prolonged immobility or trauma with prolonged immobility or cancer). VTE resulting from a transient cancer). VTE resulting from a transient major risk factor carries very low risk of major risk factor carries very low risk of antenatal recurrence.antenatal recurrence.

Page 12: DVT & PE

Patients with a single Patients with a single attack of TE outside attack of TE outside pregnancy are considered pregnancy are considered “low-risk” patients if there “low-risk” patients if there is no family history of TE is no family history of TE & no thrombophilia. They & no thrombophilia. They are treated with aspirin 75 are treated with aspirin 75 mg bd throughout mg bd throughout pregnancy switching to pregnancy switching to heparin at delivery. heparin at delivery.

Page 13: DVT & PE

Women with previous TE are to be stratified into:Women with previous TE are to be stratified into:● ● Very high risk: Women with recurrent TE associated with either Very high risk: Women with recurrent TE associated with either

antithrombin deficiency or the APS antithrombin deficiency or the APS (who will often be on long-term oral (who will often be on long-term oral

anticoagulation).anticoagulation). These women require high prophylactic (12-hourly) or These women require high prophylactic (12-hourly) or Wt-adjusted (75% of ttt dose) antenatally & for 6w PP or until Wt-adjusted (75% of ttt dose) antenatally & for 6w PP or until converted back to warfarin. converted back to warfarin.

● ● High risk: Women in whom TE was unprovoked, idiopathic or related High risk: Women in whom TE was unprovoked, idiopathic or related to E or who have other risk factors a family history of TE in a 1st-to E or who have other risk factors a family history of TE in a 1st-degree relative or a documented thrombophilia. These women require degree relative or a documented thrombophilia. These women require prophylaxis with LMWH antenat & for 6 weeks PP.prophylaxis with LMWH antenat & for 6 weeks PP.

● ● Intermediate risk: Women in whom TE was provoked by a transient Mj Intermediate risk: Women in whom TE was provoked by a transient Mj risk factor that is no longer present & who have no other risk factors risk factor that is no longer present & who have no other risk factors They require close surveillance for the develop-ment of other risk They require close surveillance for the develop-ment of other risk factors. They should be offered prophylaxis with LMWH for 6 w PP. factors. They should be offered prophylaxis with LMWH for 6 w PP.

Page 14: DVT & PE

≥ ≥3 risk factors (other than previous TE or 3 risk factors (other than previous TE or thrombophilia) and “high-risk” patients with thrombophilia) and “high-risk” patients with

multiple episodes of TE &/or a family history of multiple episodes of TE &/or a family history of TE or thrombophilia of course warrant heparin TE or thrombophilia of course warrant heparin

prophylaxis starting in the 2nd ½ of pregnancy prophylaxis starting in the 2nd ½ of pregnancy to balance the risks Vs benefits of heparin to balance the risks Vs benefits of heparin

exposure. LMWH at the lowest doses when given exposure. LMWH at the lowest doses when given for >8 w. When to start heparin prophylaxis? At for >8 w. When to start heparin prophylaxis? At least 4-6 w in advance of the gestation at which least 4-6 w in advance of the gestation at which

the previous event(s) occurred. If previous the previous event(s) occurred. If previous thrombosis was not in pregn., start after the 20thrombosis was not in pregn., start after the 20thth

w. Women receiving LMWH should be advised w. Women receiving LMWH should be advised that, if they have any vaginal bleeding or once that, if they have any vaginal bleeding or once

labour begins, they should not inject any further labour begins, they should not inject any further LMWH. They should be admitted. LMWH. They should be admitted.

Page 15: DVT & PE

Recommendations for thromboprophylaxisRecommendations for thromboprophylaxis after delivery: after delivery: ≥2 persisting ≥2 persisting risk factors risk factors (other than previous TE or thrombophilia) LMWH (other than previous TE or thrombophilia) LMWH should be given for 7 days. The same is recommended for should be given for 7 days. The same is recommended for women with BMI >40kg/mwomen with BMI >40kg/m22 & for women who have had & for women who have had emergency CS oremergency CS or an elective CS + ≥1 additional risk factors. an elective CS + ≥1 additional risk factors. Graduated compression stockings in addition to LMWH are Graduated compression stockings in addition to LMWH are given to women with ≥3 persisting risk factors.given to women with ≥3 persisting risk factors. All women All women with asymptomatic thrombophilia should be given LMWH for with asymptomatic thrombophilia should be given LMWH for ≥7 days following delivery, even if they were not receiving ≥7 days following delivery, even if they were not receiving antenatal prophylaxis. This could be extended to 6w if there antenatal prophylaxis. This could be extended to 6w if there is family history or other risk factors present. Women with is family history or other risk factors present. Women with VTE before the current pregnancy should be offered LMWH VTE before the current pregnancy should be offered LMWH for 6w following delivery. In women who have additional for 6w following delivery. In women who have additional persistent (lasting >7 days PP) risk factors, such as wound persistent (lasting >7 days PP) risk factors, such as wound infec., prophylaxis should be extended for up to 6w or until infec., prophylaxis should be extended for up to 6w or until the additional risk factors are no longer present.the additional risk factors are no longer present.

Page 16: DVT & PE

Active treatment:Active treatment: Acute phaseAcute phase HospitalisationHospitalisationHeparin:Heparin: Therapy should be commenced in suspected Therapy should be commenced in suspected

cases until the diagnosis is refuted 5000 U iv. then cases until the diagnosis is refuted 5000 U iv. then 1600 U/h by infusion (40000 U/day) for 7-10 days, 1600 U/h by infusion (40000 U/day) for 7-10 days, until reaching a bl level of 0.6U/ml or APTT 1.5-2-x the until reaching a bl level of 0.6U/ml or APTT 1.5-2-x the control; given in 10-20 ml control; given in 10-20 ml salinesaline. Antidote is . Antidote is protamine protamine

SOSO44

Thrombolytic therapy:Thrombolytic therapy: normal pulmonary capillary normal pulmonary capillary bl vol & pulmonary diffusing capacity in addition to bl vol & pulmonary diffusing capacity in addition to earlier resolution & less post-phlebitic leg symptoms. earlier resolution & less post-phlebitic leg symptoms. It may cause relative uterine atony due to the It may cause relative uterine atony due to the interference of FDPs with uterine contraction. interference of FDPs with uterine contraction.

Surgery:Surgery: Venous plication or insertion of vena caval Venous plication or insertion of vena caval umbrella prevents PE in case of ilio-femoral DVT. It is umbrella prevents PE in case of ilio-femoral DVT. It is indicated where anti-coagulant therapy is strictly indicated where anti-coagulant therapy is strictly contraindicated as in intracranial hage. Pulmonary contraindicated as in intracranial hage. Pulmonary embolectomy is considered in the following cases: 1-embolectomy is considered in the following cases: 1-shocked cases of PE 2- any of the following features shocked cases of PE 2- any of the following features 1-h later: a- S Bl P <90mm Hg; b- PaO1-h later: a- S Bl P <90mm Hg; b- PaO22 <60mmHg; c- <60mmHg; c- Urine output <20 ml/h.Urine output <20 ml/h.

Page 17: DVT & PE

Chronic phaseChronic phase for up to several months Heparin is assayed by for up to several months Heparin is assayed by anti-Xa as frequent as ANC visits. This is difficult; TT is a anti-Xa as frequent as ANC visits. This is difficult; TT is a

sensitive alternative. If the level >0.2U/ml, the dose should sensitive alternative. If the level >0.2U/ml, the dose should be reduced. Heparin is continued for the remainder of be reduced. Heparin is continued for the remainder of

pregnancy & until 6 w PP or for 3 months which is longer pregnancy & until 6 w PP or for 3 months which is longer (SQ) discontinued 24h before induction of labour & resumed (SQ) discontinued 24h before induction of labour & resumed

immediately PP. Providing APTT, TT & platelet count are immediately PP. Providing APTT, TT & platelet count are normal there is no bleeding risk at delivery, and epidural normal there is no bleeding risk at delivery, and epidural

block & CS are quite safe. After delivery reduce the dose to block & CS are quite safe. After delivery reduce the dose to 7500Ux2 daily -due to decrease in bl vol- for 6w, or only for 1 7500Ux2 daily -due to decrease in bl vol- for 6w, or only for 1

w then replaced by warfarin for 5w. Warfarin should be w then replaced by warfarin for 5w. Warfarin should be initiated within 24h of delivery & once a therapeutic INR of 2-initiated within 24h of delivery & once a therapeutic INR of 2-

3 is achieved, heparin is discontinued, & warfarin is 3 is achieved, heparin is discontinued, & warfarin is maintained for ≥6 w. While warfarin requires Rpt monitoring maintained for ≥6 w. While warfarin requires Rpt monitoring

by PT, heparin does not require monitoring after the 1st w. by PT, heparin does not require monitoring after the 1st w. Warfarin is given daily, the first 2 doses are 10 mg each then Warfarin is given daily, the first 2 doses are 10 mg each then

the INR is checked before giving the 3rd dose (for the ttt of the INR is checked before giving the 3rd dose (for the ttt of DVT INR should be 2-3; for pro-phylactic therapy a value of 2-DVT INR should be 2-3; for pro-phylactic therapy a value of 2-2.5 is sufficient; with prosthetic valves INR should be 3-4.5).2.5 is sufficient; with prosthetic valves INR should be 3-4.5).

Page 18: DVT & PE

DVT DVT - DVT often develops without symptoms or - DVT often develops without symptoms or

signs. signs. - There may be mild pyrexia. - There may be mild pyrexia. - Tender oedematous calf. However, 50% of - Tender oedematous calf. However, 50% of

patients with tender swollen calf do not have patients with tender swollen calf do not have DVT. Persistent leg swelling and/or pain with DVT. Persistent leg swelling and/or pain with tenderness rises suspicion. The affected leg tenderness rises suspicion. The affected leg may feel warmer. Careful tape measurement may feel warmer. Careful tape measurement may reveal some swelling compared with the may reveal some swelling compared with the other leg. Although deep in the groin the other leg. Although deep in the groin the femoral vein may be palpable in the femoral vein may be palpable in the condition of Phlegmasia Albna Dolens condition of Phlegmasia Albna Dolens (extreme thrombosis with complete block of (extreme thrombosis with complete block of the femoral vein causing solid oedema & the femoral vein causing solid oedema & marbled appearance of the superficial veins). marbled appearance of the superficial veins). The condition is very painful. The condition is very painful.

Page 19: DVT & PE

- - 40% of PP DVT occurs after discharge. 40% of PP DVT occurs after discharge.

- It is 8-x more common in the left leg (90% - It is 8-x more common in the left leg (90% of cases); signs and symptoms isolated to of cases); signs and symptoms isolated to the right leg reduce the probability of DVT. the right leg reduce the probability of DVT.

- Most cases (72%) are iliofemoral. C/o Most cases (72%) are iliofemoral. C/o lower abdominal pain, O/E pyrexia, in lower abdominal pain, O/E pyrexia, in addition to leucocytosis. Differential addition to leucocytosis. Differential diagnosis is UTI and appendicitis. diagnosis is UTI and appendicitis.

- Clinically DVT should be differentiated - Clinically DVT should be differentiated from Baker’s cyst, muscle strain or from Baker’s cyst, muscle strain or haematoma, myositis, neurogenic pain haematoma, myositis, neurogenic pain and arthritis. and arthritis.

Page 20: DVT & PE

- C reactive ptn: Normal values R/O DVT - C reactive ptn: Normal values R/O DVT -Impending plethysmography is inexpens -Impending plethysmography is inexpens

bedside non-invasive & sensitive (to bedside non-invasive & sensitive (to obstruc. in venous outflow). It is obstruc. in venous outflow). It is effective at testing for the presence or effective at testing for the presence or development (impending)of thrombosis development (impending)of thrombosis particularly proximal DVT. It is per-particularly proximal DVT. It is per-formed in the Lt lateral position; the formed in the Lt lateral position; the position should also be adopted for 20 position should also be adopted for 20 min before testing. +ve tests min before testing. +ve tests (particularly in the 3rd trimester) (particularly in the 3rd trimester) should be confirmed by venography or should be confirmed by venography or US because what constitutes +ve tests US because what constitutes +ve tests in pregnancy is not yet known. Serially in pregnancy is not yet known. Serially -ve tests rule out clinically significant -ve tests rule out clinically significant DVT (anticoagulant ttt can be withheld DVT (anticoagulant ttt can be withheld safely). safely).

Page 21: DVT & PE

- Ultrasound is highly effective (sensitivity & specificity = - Ultrasound is highly effective (sensitivity & specificity = 97% for proximal vein thrombosis). The clot may be seen 97% for proximal vein thrombosis). The clot may be seen & the vein is incompressible and does not dilate during a & the vein is incompressible and does not dilate during a Valsalva manoevure. US is helpful at identifying other Valsalva manoevure. US is helpful at identifying other causes of leg swelling such as haematoma or Baker’s cyst.causes of leg swelling such as haematoma or Baker’s cyst.

- Venography: In spite of being ‘the gold standard’ for the - Venography: In spite of being ‘the gold standard’ for the diagnosis of DVT, is reserved for centers where diagnosis of DVT, is reserved for centers where plethysmography or ultrasound are not available, and to plethysmography or ultrasound are not available, and to confirm a +ve plethysmography test. It is confirm a +ve plethysmography test. It is painfulpainful; costly; ; costly; contrast contrast nephrotoxicity & allergy; and shielding reduces nephrotoxicity & allergy; and shielding reduces visualization of the iliac veins & isolated thrombosis in visualization of the iliac veins & isolated thrombosis in them will not be detected. them will not be detected.

- Specificity and sensitivity of Doppler ultrasound to - Specificity and sensitivity of Doppler ultrasound to diagnose DVT in proximal veins are higher than in distal diagnose DVT in proximal veins are higher than in distal veins. veins.

- Isotop localisation: Radioactive iodine-labelled fibrinogen is - Isotop localisation: Radioactive iodine-labelled fibrinogen is injected. It will be deposited at the site of the thrombus, injected. It will be deposited at the site of the thrombus, and this can be detected using a scintillation counter over and this can be detected using a scintillation counter over the suspected vein. The thyroid must be protected by the suspected vein. The thyroid must be protected by earlier injection of sodium iodide. The technique is only earlier injection of sodium iodide. The technique is only applicable postnatally to non-lactating women. applicable postnatally to non-lactating women.

Page 22: DVT & PE

RisksRisks 1- Proximal DVT has a high probability of 1- Proximal DVT has a high probability of

major embolization to the lungs and major embolization to the lungs and should be treated. Calf vein thrombosis should be treated. Calf vein thrombosis negligible risk of embolization provided it negligible risk of embolization provided it remains confined to the calf. remains confined to the calf.

2- Postphlebitic syndrome (chronic venous 2- Postphlebitic syndrome (chronic venous insufficiency): Swelling, varicose veins, insufficiency): Swelling, varicose veins, pain, eczema, skin changes and pain, eczema, skin changes and ulceration. ulceration.

Page 23: DVT & PE

Pulmonary embolismPulmonary embolism The risk of pulmonary embolism with The risk of pulmonary embolism with

thrombosis limited to calf muscles = 1%, thrombosis limited to calf muscles = 1%, but rises to 50% if the ilio-femoral vessels but rises to 50% if the ilio-femoral vessels are involved. However, in up to 70% of are involved. However, in up to 70% of cases there are no signs of DVT. Risk of cases there are no signs of DVT. Risk of pulmonary embolism in treated cases of pulmonary embolism in treated cases of DVT is still high although much less than in DVT is still high although much less than in untreated cases (4.5:20%). Other risk untreated cases (4.5:20%). Other risk factors include excessive blood loss and factors include excessive blood loss and blood group other than O. blood group other than O.

Page 24: DVT & PE

DiagnosisDiagnosis Massive PE = Massive PE = 60% of pulmonary circulation is involved. It presents with 60% of pulmonary circulation is involved. It presents with

collapse, chest pain (occasionally abdominal pain probably due to collapse, chest pain (occasionally abdominal pain probably due to irritation of the diaph) breathlessness & cyanosis. O/E: There is hypo-irritation of the diaph) breathlessness & cyanosis. O/E: There is hypo-tension, may be a 3rd heart sound, parasternal heave & elevated jugular tension, may be a 3rd heart sound, parasternal heave & elevated jugular venous pressure. Major embolism is often preceded by small emboli with venous pressure. Major embolism is often preceded by small emboli with syncope, pleuretic chest pain, tachypne breathlessness cough & syncope, pleuretic chest pain, tachypne breathlessness cough & unexplained pyrexia. Bronchospasm may be a feature. Chest X-ray is unexplained pyrexia. Bronchospasm may be a feature. Chest X-ray is useful in excluding other diseases&interpreting the ventilation useful in excluding other diseases&interpreting the ventilation /perfusion lung scan. lLvel of OH-butarate dehydrogenase is high. ECG: /perfusion lung scan. lLvel of OH-butarate dehydrogenase is high. ECG: There is right heart strain. S1 Qiii Tiii are diagnostic of major PE. ECG & There is right heart strain. S1 Qiii Tiii are diagnostic of major PE. ECG & CXR may be normal. ABG has false +ve & false -ve results although with CXR may be normal. ABG has false +ve & false -ve results although with PPaOaO22 <70mmHg & normal or low <70mmHg & normal or low PPaCOaCO22 the chest symptoms are likely to the chest symptoms are likely to be due to PE. be due to PE.

Pulmonary angiography: In spite of being ‘the gold standard’ for the Pulmonary angiography: In spite of being ‘the gold standard’ for the diagnosis of PE, it is invasive; costly; contrast diagnosis of PE, it is invasive; costly; contrast allergy; in addition to allergy; in addition to exposing the patient to high levels of radiation. It is indicated in severe exposing the patient to high levels of radiation. It is indicated in severe cases in which surgery may be required. cases in which surgery may be required.

In the non-acute situation V/Q lung scan is the pivotal test having a very In the non-acute situation V/Q lung scan is the pivotal test having a very high -ve predictive value (ttt can be withhold safely) “High-probability” high -ve predictive value (ttt can be withhold safely) “High-probability” lung scan = segmental or large subsegmental perfusion defect with lung scan = segmental or large subsegmental perfusion defect with normal ventilation “Non-high-probability” lung scan should be followed normal ventilation “Non-high-probability” lung scan should be followed by U.S. or IPG. If -ve, pulmonary angiography is performed. by U.S. or IPG. If -ve, pulmonary angiography is performed.

If the patient does not die, she will recover completely with few patients If the patient does not die, she will recover completely with few patients have symptomatic pulmonary hypertension & abnormal lung function have symptomatic pulmonary hypertension & abnormal lung function tests. Lung scan if normal excludes PE. A large perfusion defect with tests. Lung scan if normal excludes PE. A large perfusion defect with normal CXR is normal CXR is likelylikely to be due to PE. A reduction in perfusion with to be due to PE. A reduction in perfusion with maintenance of ventilation maintenance of ventilation indicatesindicates PE. PE.

In the future low D-dimer FDP will be used to exclude PE. In the future low D-dimer FDP will be used to exclude PE.

Page 25: DVT & PE

TreatmentTreatment

Massive pulmonary embolus: Cardiac Massive pulmonary embolus: Cardiac arrest procedure (prolonged cardiac arrest procedure (prolonged cardiac massage may break up the original massage may break up the original clot) + heparin 20 000U i.v. to clot) + heparin 20 000U i.v. to reverse the broncho- and vaso-reverse the broncho- and vaso-constrictions caused by the release constrictions caused by the release of serotonin from platelets. Acute of serotonin from platelets. Acute and chronic phases. and chronic phases.

Page 26: DVT & PE

ThanThankk

you you